Sales rise 6.42% to Rs 235.25 crore
Net profit of Marksans Pharma rose 72.54% to Rs 24.88 crore in the quarter ended June 2018 as against Rs 14.42 crore during the previous quarter ended June 2017. Sales rose 6.42% to Rs 235.25 crore in the quarter ended June 2018 as against Rs 221.06 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales235.25221.06 6 OPM %15.0913.12 -PBDT36.3227.10 34 PBT30.3619.66 54 NP24.8814.42 73Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content